Simple Summary Breast cancers that lack expression of the predictive markers oestrogen
receptor, progesterone receptor and human epidermal growth factor receptor-2 are known …

Triple-negative breast cancers (TNBC) comprise biologically and clinically heterogeneous
diseases characterized by the lack of hormone receptors (HR) and HER2 expression. This …

Context.—Mucinous lesions of the breast encompass many entities ranging from benign to
malignant and nonneoplastic to neoplastic. Lesions discussed under this category are …

Mucoepidermoid carcinoma (MEC) is often seen in salivary glands and can harbor MAML2
translocations (MAML2+). The translocation status has diagnostic utility as an objective …

Mucoepidermoid carcinoma (MEC) of the breast is an extremely rare salivary gland‐type
tumor characterized by epidermoid, basaloid, intermediate, and/or mucinous cells arranged …

Triple-negative breast carcinomas constitute a wide spectrum of lesions, mostly being highly
aggressive. Nevertheless, some special histologic subtypes can have low malignant …

Breast mucoepidermoid carcinoma (MEC) is clinically rare, with an estimated incidence of
0.2-0.3% of all primary breast tumors. To date, only 41 cases have been reported in the …

GATA3 is the most used marker to determine tumors' breast origin, but its diagnostic value in
triple-negative breast cancer (TNBC) is limited. The newly identified TRPS1 is highly …

Context The World Health Organization classification of tumors of the breast recognizes
several special type carcinomas and benign lesions with features comparable to those of …

Interventions: The patient underwent breast-conserving surgery, adjuvant chemotherapy,
radiotherapy, and hormonal therapy. Outcomes: No evidence of recurrence has been …